LASERSCOPE
8-K, 2000-03-01
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: RAMTRON INTERNATIONAL CORP, SC 13D/A, 2000-03-01
Next: KEMPER GLOBAL INCOME FUND, NSAR-B, 2000-03-01



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934



         Date of Report (Date of earliest event reported): MARCH 1, 2000

                                   LASERSCOPE
             (Exact name of Registrant as specified in its charter)


<TABLE>
<S>                                        <C>                                  <C>
        CALIFORNIA                              0-18053                            77-0049527
(State or other jurisdiction of           (Commission File Number)              (I.R.S. Employer
incorporation or organization)                                                 Identification No.)
</TABLE>




                               3052 ORCHARD DRIVE
                               SAN JOSE, CA 95134
               (Address of principal executive offices) (Zip code)


                                 (408) 943-0636
              (Registrant's telephone number, including area code)

                                 NOT APPLICABLE
          (Former name or former address, if changed since last report)


<PAGE>   2



ITEM 5.  OTHER EVENTS

     (a) On February 22, 2000 Laserscope (the "Company") issued a press release
announcing that it had completed a private placement of subordinate convertible
debentures providing net proceeds to the Company of approximately $2.9 million.
The placement to affiliates of Renaissance Capital Group, Inc., was managed by
Taglich Brothers Inc.



ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

         (a)      Not applicable.

         (b)      Not applicable.

         (c)      Exhibits.
                  --------

                  20.1     Press Release dated February 22, 2000 announcing the
                            private placement. [See Exhibit Index.]




<PAGE>   3




                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.



                                   LASERSCOPE
                                  (Registrant)


Date:  March 1, 2000              By: /s/ Dennis Lalumandiere
                                      -----------------------
                                      Dennis LaLumandiere
                                      Vice President, Finance,
                                      Chief Financial Officer and
                                      Assistant Secretary



<PAGE>   4



                                INDEX TO EXHIBITS

<TABLE>
<CAPTION>
                                                                   SEQUENTIALLY
EXHIBIT                                                               NUMBERED
NUMBER      DESCRIPTION                                                 PAGE
- -------     -----------                                            ------------
<S>          <C>                                                   <C>
20.1        PRESS RELEASE DATED FEBRUARY 22, 2000 ANNOUNCING              5
            THE PRIVATE PLACEMENT.

</TABLE>


<PAGE>   1
                                                                  Exhibit 20.1


LASERSCOPE COMPLETES SECOND PRIVATE FINANCING

SAN JOSE, Calif.--(BW HealthWire)--Feb. 22, 2000--Laserscope (Nasdaq: LSCP -
news) today announced that it completed a private placement of subordinate
convertible debentures with net proceeds to the Company of approximately $2.9
million. The placement to affiliates of Renaissance Capital Group, Inc., was
managed by Taglich Brothers, Inc. (s/k/a Taglich Brothers, D'Amadeo, Wagner &
Company, Incorporated).

The debentures mature seven years from issuance and bear an interest rate of
8.00%. For the first three years, installments will consist of monthly interest
payments only. The debentures are convertible into common stock of the Company,
with an initial conversion price, which is subject to adjustment, of $1.25.

On January 18, 2000 the Company also completed a private placement of common
stock providing net proceeds to the Company of approximately $1.8 million. The
proceeds from both placements will be used for general corporate purposes.

Laserscope designs, manufactures, sells and services on a worldwide basis an
advanced line of medical laser systems and related energy delivery devices for
the office, outpatient surgical center, and hospital markets. More information
about Laserscope can be found on the Company's Web Site at www.laserscope.com.

Except for historical information presented, the matters discussed in this
announcement may contain forward-looking statements that involve risks and
uncertainties. These risks are detailed from time to time in the Company's
public disclosure filings with the U.S. Securities and Exchange Commission
(SEC). Copies of Laserscope's most recent forms 10K and 10Q are available upon
request from its Investor Relations Department.

Contact:
     Laserscope
     Eric Reuter, 408/943-0636 (President & CEO)
     Dennis LaLumandiere, 408/943-0636 (CFO)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission